Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AON), associated with the symbol AONC, appears frequently in public news releases as a rapidly growing community oncology network. These announcements highlight how AON partners with community-based oncology and hematology practices across multiple states, bringing together physicians and healthcare leaders focused on delivering cancer care close to where patients live and work.
News about American Oncology Network often covers the expansion of its national network, including new partner practices, new clinic locations, and the recruitment of additional board-certified medical oncologists and hematologists. Releases describe practices in states such as Arkansas, Maryland, Texas, and Hawai’i joining or expanding within the network, illustrating AON’s emphasis on community-based care.
Another recurring theme in AON-related news is the development of advanced clinical capabilities and research. Examples include the growth of radiotheranostic and radioligand therapy services at partner practices, the appointment of a radiology medical director and in-house reading radiologist, and the activities of American Oncology Research (AOR), which supports clinical trials in the community setting. AOR’s alliance with Meaningful Insights Biotech Analytics to integrate AI-enhanced data into clinical research within the American Oncology Network is also featured.
In addition, AON news items describe participation in national oncology meetings and research symposia, with multiple abstracts accepted at American Society of Clinical Oncology events. These stories focus on value-based care, cost of care, reimbursement, and social risk factors in oncology. Visitors to the AONC news page can expect coverage of network growth, physician additions, clinic openings, research collaborations, and initiatives aimed at improving access, quality, and equity in community oncology.
American Oncology Network (AONC) announced the expansion of radioligand therapy (RLT) access across its network, with six community oncology practices now offering these advanced cancer treatments. The network has already administered over 300 treatments to nearly 70 patients across five partner practices.
The practices offer three FDA-approved radiopharmaceuticals: Pluvicto™ for metastatic castration-resistant prostate cancer, Lutathera® for gastroenteropancreatic neuroendocrine tumors, and Xofigo® for symptomatic mCRPC with bone metastases. RLT works by delivering targeted radiation directly to cancer cells while minimizing damage to healthy tissue.
American Oncology Network (AONC) has appointed Joe Verschleiser as Chief Growth and Performance Officer. In his new role, Verschleiser will lead growth strategy and performance optimization for AON partner practices, focusing on expansion and new business line opportunities. He brings over a decade of healthcare experience, including executive leadership roles at Unified Women's Healthcare, where he served as president of the West Division overseeing operations for more than 200 physicians. His previous experience includes positions in financial strategy, mergers and acquisitions, and investment banking at firms like Jefferies and Rothschild & Co.
Dr. Sakeer Hussain, a medical oncologist at Heartland Oncology and Hematology, has been named a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The recognition was announced during ASCO's annual Advocacy Summit in Washington, D.C. Dr. Hussain was honored for his significant contributions to cancer policy advancement, including meetings with congressional leaders, testifying before the Iowa House of Representatives, and hosting his local congressman to showcase community oncology care.
His advocacy work has focused on critical issues such as drug shortages, research funding, telehealth access, prior authorization reform, and opposing non-medical switching. Dr. Hussain's efforts align with ASCO's mission to support high-quality, equitable cancer care, regardless of patients' geography, income, or background.
American Oncology Network (AONC) has appointed Terri Casey as its new Chief Human Resources Officer (CHRO). Casey brings over 15 years of experience leading HR teams, with extensive background in executive leadership roles across various physician specialty practices including orthopedics, rehabilitation, aesthetics, and mental health. She also has significant experience in employment law, having worked at a boutique law firm and served as general counsel specializing in healthcare industry matters.
Casey holds a Bachelor and Master of Science from Virginia Commonwealth University and a Juris Doctor from John Marshall Law School. Prior to this permanent appointment, she served as interim CHRO for several healthcare organizations, including AON. In her new role, she will focus on strengthening workplace culture, talent development, and supporting AON's mission to make cancer care affordable and accessible across communities.
American Oncology Network (AON) announced its participation in 14 speaking sessions at the 2025 Community Oncology Alliance (COA) Annual Conference in Orlando, Florida, April 29-30. The conference, themed 'Empower & Advocate: Independent Community Oncology,' will feature AON leaders discussing various aspects of community oncology.
Chief Medical Officer Dr. Stephen Divers and Chief Strategy Officer Alti Rahman will serve as conference co-chairs. Presentations will cover important topics including:
- Payer contracting and value-based care
- Clinical trials infrastructure
- Patient advocacy and mental health programs
- Radiopharmaceutical therapies
- Practice partnerships and innovation
The event demonstrates AON's commitment to supporting local practices through comprehensive services including in-house pharmacy, lab services, and back-office operations, enabling physicians to focus on community-based patient care.
American Oncology Network (AON) has reported significant success in the first performance period of the Centers for Medicare & Medicaid Innovation's (CMMI) Enhancing Oncology Model (EOM). The company achieved nearly $6M in cost savings for CMS while earning a performance-based payment and improving patient outcomes.
Building on their previous success in the Oncology Care Model (OCM), where they saw a 2.6% decrease in expenditures, AON practices now represent approximately 10% of the total EOM population. The success was driven by several key initiatives implemented in partnership with Thyme Care, including:
- Pharmacy interventions focusing on drug waste minimization and therapeutic substitutions
- 24/7 comprehensive care navigation with virtual support
- Real-time performance data analytics
- Virtual palliative care support
American Oncology Network (AON) announced the appointment of Anne Marie Rainey, their director of value-based care, to the Association of Cancer Care Centers' Board of Trustees. Rainey, who manages internal quality, government, and value-based care initiatives at AON, brings experience from her work with the Centers for Medicare & Medicaid Services and the Centers for Disease Control and Prevention.
With a Master of Science in Nursing in leadership and administration, Rainey's focus in community oncology includes quality metrics analysis, program implementation, health policy, and community oncology advocacy. The appointment was announced at ACCC's 51st Annual Meeting & Cancer Center Business Summit in March 2025, where new board members were confirmed for two-year terms to advance quality cancer care delivery.
MidAmerica Cancer Care (MACC) has opened a new medical oncology clinic in Kansas City, Kansas at 8919 Parallel Pkwy. The facility features private exam rooms, an infusion room, in-house lab and pathology services, and a specialty pharmacy for oral oncolytics.
The clinic is staffed by board-certified medical oncologists Jaswinder Singh, MD, Nicholas Shuler, DO, Shajadi Patan, MD, and Benjamin Fangman, MD. As a community-based practice, MACC provides affordable cancer care across the Kansas City Metropolitan area and western Missouri.
This expansion follows MACC's recent partnership with American Oncology Network (AON) announced in January, enhancing their service offerings including access to in-house specialty pharmacy with home delivery of certain medications.
FAQ
What is the current stock price of American Oncology Network (AONC)?
What is the market cap of American Oncology Network (AONC)?
